Brendan Hannah - CBO, COO & CCO at Quince Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Cbo, Coo & Cco
Issuer Symbol
QNCX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Brendan Hannah since 10 Mar 2025

Holdings reported by Brendan Hannah for Quince Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 361,827 $340,117 $0.9400 05 Dec 2025 Direct
Warrants 37,736 $4,717 $0.1250 18 Jun 2025 Direct Common Shares
Employee Stock Option (Right to Buy) 365,000 23 Jan 2026 Direct Common Shares

Transactions reported by Brendan Hannah for Quince Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.